Search

everythinglearnresearchcommunity

for

Search:↓

Some vaccines might rarely cause hair loss, more research is needed.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

A rare scalp condition causing hair loss and cysts in young men can be treated effectively with a specific steroid injection.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Mutant mice help researchers understand hair growth and related genetic factors.

The combined laser and plasma jet therapy effectively regrew hair in a woman with alopecia areata.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

New biomaterial treatments for baldness show promise, with options depending on patient needs.

Animal models are crucial for learning about hair loss and finding treatments.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Tinea capitis should be considered in adults with scalp issues for proper treatment.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Oral Apremilast effectively treats alopecia areata in most patients.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.